WHO rules have to have manufacturers to carry out a ongoing chance administration method for sterility test isolators, which includes normal risk assessments and the event of threat-dependent control approaches. The risk management system starts with a thorough Assessment of likely failure modes and their opportunity impacts on sterility Successfully Submitted (Awaiting Approval)